|
| Ref. | Age (y)/Sex | Size (cm) | Location | Smoking | Obstructive
symptoms | Immunohistochemical data |
| Inner cell | Outer cell |
|
| [5] | Average 55.5 (54-57)/M (1), F (3) | Median 1.5
(1.5-5.0) | E | NA | +(3) NA (1) | EMA(+); MNF116(+); and CD34(-) | S-100(+); SMA(+); and vim(+) |
| [6] | 51/F | 3.3 | P | NA | - | EMA(+); TTF-1(+) | S-100(+); actin(+) |
| [7] | 76/F | 2.7 | P, U | NA | - | CK(+); EMA(+); CEA(+); and TTF-1(+) | S-100(+); actin(+); P63(+); CD10(+); and P27/kip-1(+) |
| [9] | 7/M | 3.6 | E | - | - | CK(+); AE1/3(+); and S-100(-) | S-100(+); SMA(+) |
| [11] | 54/F | 1.5 | E | + | - | CK7(+) | S-100(+); SMA(+); P63(+); and CK5/6(+) |
| [12] | Average 56.6 (52-62)/M (0), F (5) | Median 1.2
(0.6-2.6) | P | NA | +(1) -(4) | EMA(+); CK7(+); CK20(-); SPA(+); CAM5.2(+); and TTF-1(+) | S-100(+); SMA(+); CK(+); P63(+); and calponin (+) |
| [13] | Average 49.6 (38-56)/M (3), F (2) | Median 3
(2.5-5) | E | NA | - | CK(+); S-100(-); and SMA(-) | S-100(+); SMA(+); CK(+); CD117(+); and GFAP(+) |
| [14] | 81/M | 0.4 | E | NA | - | CK(+) | S-100(+); P63(+); TTF-1(-); MIB-1(10%); and p27/kip-1(+) |
| [15] | Average 60.4 (52-66)/M (3), F (2) | Median 1.8
(0.7-12) | E | +(3) | +(4) -(1) | CK(+); TTF-1(+) | S-100(+); S-100(-); SMA(+); and P27(+) |
| [16] | 53/F | 2.2 | E | - | + | CK(+) | S-100(+); SMA(+) |
| [17] | Average 52.5 (35-69)/M (2), F (6) | Median 2.5
(2.0-16.0) | E (5), P, U (3) | NA | + | CAM5.2(+); S-100(+); and CK(+) | HHF35(+); S-100(+) |
| [18] | 55/F | 2.0 | E | + | + | CK(+); CAM5.2(+) | S-100(+); SMA(+); vim(+); and GFAP(+) |
| [19] | 66/M | 16 | E | + | NA | CEA(+); EMA(+); and AE3(+) | S-100(+); SMA(-); AE3(+/-); and GFAP(+) |
| [20] | 55/F | 3.9 | E | - | + | CK(+); GEAP(-) | S-100(+); SMA(+); and GFAP(-) |
| [21] | 47/F | NA | E | - | + | CK(+); SMA(-) | S-100(-); SMA(+);
CK(+); and vim(+) |
| [22] | 67/M | 1.3 | E | + | + | CAM5.2(+); AE1/3(+) | S-100(+); SMA(+) |
| [23] | 73/M | 4.5 | E | + | + | EMA(+); CK(+); S-100(-); and vim(-) | S-100(+); SMA(+); and vim(+) |
| [24] | 73/M | 3.8 | E | + | + | CK(+); EMA(+); and P53(+) | S-100(+); SMA(+); GFAP(+); and P53(+) |
| [25] | 35/F | 13.0 | E | NA | + | SMA(+); CD10(+) | S-100(+); SMA(+); CD10(+); and GFAP(+) |
| [26] | 43/F | NA | E | - | + | CK7(+); EMA(+); P53(+); and CD117(+) | S-100(+); SMA(+); P53(+); and CD117(+) |
| [27] | 74/M | 1.5 | E | + | + | S-100(+); SMA(+); and vim(+) | S-100(+); vim(+) |
| [28] | Average 57/M (1), F (1) | Median 6.9 | NA | NA | NA | NA | NA |
| [29] | 57/M | 2.0 | E | + | - | CAM5.2(+); AE1/AE3(+); CK7(+); and CK903(+) | S-100(+); SMA(+); GFAP(+); calponin(+); CD117(+); and P27/kip1(+) |
| [30] | Average 63 (36-75)/M (3), F (4) | Median 2.5
(1.3-4.0) | NA | NA | +(3) | NA | NA |
| [31] | 34/M | 1.15 | E | NA | + | CK7(+); CK8/18(+) | S-100(+); SMA(+); and P63(+) |
| [32] | 72/F | 3.8 | E | - | - | AE1/AE3(+) | SMA(+); P63(+) |
| [33] | 58/M | 1.3 | P, U | - | - | CK(+); CEA(+); and TTF-1(+) | S-100(+); CD10(+); P63(+); and P40(+) |
| [34] | 58/F | 1.5 | E | NA | - | CK7(+) | S-100(+); SMA(+); and P63(+) |
| [35] | 83/F | 8.3 | E | + | + | CK(+); TTF-1(-) | S-100(+); actin(+); vim(+); and TTF-1(-) |
| [36] | 72/M | 3.5 | U | NA | - | NA | NA |
| [37] | 50/F | 3.5 | E | - | + | CK7(+); TTF-1(-) | S-100(+); SMA(+); P40(+); and TTF-1(-) |
| [38] | 45/F | 5.4 | E | - | + | CK(+); AB(+); and TTF-1(-); | S-100(+); SMA(+); and PAS(-) |
| [39] | 55/M | 1.9 | E | + | + | AE1/AE3(+); CD117(+) | S-100(+); SMA(-); P40(+); and P63(+) |
| [40] | 30/F | NA | E | NA | + | NA | NA |
| [41] | 76/F | 2.7 | E | NA | + | CK(+); vim(-) | S-100(+); P63(+); HHF(+); and CK(+) |
| [42] | 70/F | 5.0 | E | + | + | CK7(+); CD117(+); CK8(+); and TTF(-) | S-100(+); SMA(+); CK5/6(+); P63(+); and P40(+) |
|
